A Florence woman told us how a modern COPD treatment at Christ Hospital helped her to be able to do things she couldn't do ...

Discover how cell-based therapy is emerging as a promising treatment option for COPD patients. Learn about its benefits, ...

The company has launched Nebzmart® GFB Smartules® and Glenmark Airz® FB Smartules®, world's first nebulised, fixed-dose ...

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced the completion of its Phase IIa clinical study for 9MW1911, a self-developed ...

A Chinese Phase IIb trial of the mAb has already started, with Mabwell also hoping to initiate a Phase IIa trial in the US.

The procedure is called bronchoscopic lung volume reduction. It involves inserting small valves into the air tubes of the ...

Unlike the West, where smoking remains the dominant driver, India’s COPD burden is shaped by pollution, says Dr Anurag ...

The new framework, which classifies the severity of exacerbations of COPD based on three key factors was developed by the ...

The 2026 version of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy report has been published. Key ...

It may be a little later than normal, but snowy weather caused havoc on Interstate 80 with a string of accidents that shut ...

She told us her life changed when she sought treatment at Christ Hospital and met Dr. Duane Allen, a pulmonary and critical ...

The global monoclonal antibody for asthma and COPD market size was valued at USD 34.02 billion in 2025 and is predicted to ...